Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Pearl Biotechnology Limited Liability Company

Clinical trials sponsored by Beijing Pearl Biotechnology Limited Liability Company, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New pill targets deadly brain tumor in patients with rare gene fusion

Disease control Ongoing

This study tests a new drug called vebreltinib for people with a certain type of recurrent brain cancer (glioblastoma) that has a specific gene change (ZM fusion). About 84 participants will either receive vebreltinib capsules or standard chemotherapy. The main goal is to see if …

Phase: PHASE2, PHASE3 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated May 14, 2026 12:03 UTC